809 — Global Bio-chem Technology Co Income Statement
0.000.00%
Last trade - 00:00
- HK$792.76m
- HK$5.10bn
- HK$1.37bn
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | HKAS | HKAS | HKAS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,561 | 849 | 747 | 12.7 | 1,374 |
Cost of Revenue | |||||
Gross Profit | 204 | 74.1 | 48.4 | 7.33 | 43.6 |
Selling / General / Administrative Expenses | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,032 | 2,533 | 363 | 752 | -3,077 |
Operating Profit | -471 | -1,684 | 383 | -740 | 4,451 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1,077 | -2,411 | -409 | -1,425 | 3,701 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,116 | -2,433 | -435 | -1,378 | 3,743 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,068 | -2,430 | -401 | -1,443 | 4,225 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,068 | -2,430 | -401 | -1,443 | 4,225 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.16 | -0.241 | -0.14 | -0.145 | 0.077 |